Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 28 most recent Form 4 transactions.
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 29,747 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 29,747 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 7,639 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 7,639 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 19,441 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 19,441 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 21,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 21,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 11,650 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 11,650 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 14,777 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 14,777 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 29,555 | — | — | — | Open the original filing on SEC.gov |
| Jul 16 | STOK | Stoke Therapeutics, Inc. | GGIFT◆ | 29,555 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 17,786 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 26,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 26,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 9,398 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 148,063 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 136,301 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 3, 2025 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 29,747 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 9,398 | — | — | +6.9% | Open the original filing on SEC.gov |